| TTM
|
4/30/2026
|
4/30/2025
|
4/30/2024
|
4/30/2023
|
|
|---|---|---|---|---|---|
| Total Revenue
|
0 | 0 | 0 | 0 | 0 |
| Selling, General and Administrative Expenses
|
-6,117.1200 | -5,137.0560 | -3,081.8960 | -3,482.5380 | -7,424.6090 |
|
Research and Development Expenses
|
-2,974.9160 | -3,629.7850 | -1,414.9280 | -6,455.1070 | -7,445.8570 |
|
Operating Income/Expenses
|
-9,092.0360 | -8,766.8410 | -4,496.8240 | -9,937.6450 | -14,870.4660 |
|
Total Operating Profit/Loss
|
-9,092.0360 | -8,766.8410 | -4,496.8240 | -9,937.6450 | -14,870.4660 |
| Total Net Finance Income/Expense
|
-4.6640 | -5.5410 | -18.0290 | -10.1010 | -7.7010 |
| Irregular Income/Expenses
|
-- | -- | -- | -- | 0 |
|
Non-Operating Income/Expenses, Total
|
-4.6640 | -5.5410 | -18.0290 | -10.1010 | -7.7010 |
|
Pretax Income
|
-9,096.7000 | -8,772.3820 | -4,514.8530 | -9,947.7460 | -14,878.1670 |
|
Net Income from Continuing Operations
|
-9,096.7000 | -8,772.3820 | -4,514.8530 | -9,947.7460 | -14,878.1670 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-9,096.7000 | -8,772.3820 | -4,514.8530 | -9,947.7460 | -14,878.1670 |
|
Net Income after Non-Controlling/Minority Interests
|
-9,096.7000 | -8,772.3820 | -4,514.8530 | -9,947.7460 | -14,878.1670 |
| Preferred/Other Stock Distribution
|
0 | 0 | -590.2310 | 0 | -- |
|
Net Income Available to Common Stockholders
|
-9,096.7000 | -8,772.3820 | -5,105.0840 | -9,947.7460 | -14,878.1670 |
|
Diluted Net Income Available to Common Stockholders
|
-9,096.7000 | -8,772.3820 | -5,105.0840 | -9,947.7460 | -14,878.1670 |
| Basic EPS
|
-2.30 | -2.63 | -11.32 | -132.33 | -228.90 |
| Diluted EPS
|
-2.30 | -2.63 | -11.32 | -132.33 | -228.90 |
|
Basic Weighted Average Shares Outstanding
|
3,930.3110 | 3,337.1430 | 450.7990 | 75.1740 | 65.0130 |
|
Diluted Weighted Average Shares Outstanding
|
3,930.3110 | 3,337.1430 | 450.7990 | 75.1740 | 65.0130 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-9,092.0360 | -8,766.8410 | -4,496.8240 | -9,937.6450 | -14,870.4660 |
|
EBITDA
|
-8,981.2960 | -8,656.1010 | -4,446.0840 | -9,886.9050 | -14,847.4000 |
|
Normalized EBITDA
|
-8,239.4720 | -7,948.5740 | -4,120.9760 | -8,931.2720 | -11,222.1860 |
|
Normalized Income
|
-8,354.8760 | -8,064.8550 | -4,189.7450 | -8,992.1130 | -11,252.9530 |
|
Total Unusual Items
|
741.8240 | 707.5270 | 325.1080 | 955.6330 | 3,625.2140 |
|
Total Unusual Items Excluding Goodwill
|
741.8240 | 707.5270 | 325.1080 | 955.6330 | 3,625.2140 |
|
Tax Effect of Unusual Items
|
0 | 0 | 0 | 0 | 0 |
|
Tax Rate, Calculated
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
4/30/2023 - 6/15/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade